Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
oda_NotificationAboutNewsOrRumoursAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
-Unofficial Translation- It was decided to make a statement in order to inform our valued investors, upon inquiries from our investors regarding the news on counterfeit medicine in various media. As stated in the subjected news , our company is the only authorized and official distributor of the subject drug (ICLUSIG) in Türkiye. There is no accusation or claim regarding our company in the news. Again, as stated in the news, counterfeit drugs were purchased by institutions since the supply was made through other channels instead of our company, which is the authorized distributor of the drug. Since its establishment, our company has been making efforts for patients' access to treatment with its patient-oriented solutions. Our company supplies the drugs that it manufactures or sells and distributes to the institutions or patients by compliyng strict formalities stipulated by the legislation, including quality control analyzes and approved serial release procedures. All subjected process has been followed and realized regarding the subjected drug in collaboration with the licensor firm. As a matter of fact, in the follow-up of the forgery mentioned in the news, our Company has performed all its duties in cooperation with the licensor company. Reiterating that there is no negative claim or determination against our Company in the news that was reflected in the press; We inform the public that it is evaluated that the news will not have a negative impact on the activities of our Company. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.